142 related articles for article (PubMed ID: 8063762)
1. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.
Czubayko F; Riegel AT; Wellstein A
J Biol Chem; 1994 Aug; 269(33):21358-63. PubMed ID: 8063762
[TBL] [Abstract][Full Text] [Related]
2. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
Grzelinski M; Bader N; Czubayko F; Aigner A
Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
Malerczyk C; Schulte AM; Czubayko F; Bellon L; Macejak D; Riegel AT; Wellstein A
Gene Ther; 2005 Feb; 12(4):339-46. PubMed ID: 15496960
[TBL] [Abstract][Full Text] [Related]
4. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.
Czubayko F; Schulte AM; Berchem GJ; Wellstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14753-8. PubMed ID: 8962127
[TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
7. An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin.
Satyamoorthy K; Oka M; Herlyn M
Pigment Cell Res; 2000; 13 Suppl 8():87-93. PubMed ID: 11041363
[TBL] [Abstract][Full Text] [Related]
8. Pleiotrophin stimulates fibroblasts and endothelial and epithelial cells and is expressed in human cancer.
Fang W; Hartmann N; Chow DT; Riegel AT; Wellstein A
J Biol Chem; 1992 Dec; 267(36):25889-97. PubMed ID: 1464602
[TBL] [Abstract][Full Text] [Related]
9. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.
Choudhuri R; Zhang HT; Donnini S; Ziche M; Bicknell R
Cancer Res; 1997 May; 57(9):1814-9. PubMed ID: 9135027
[TBL] [Abstract][Full Text] [Related]
10. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
Perez-Pinera P; Chang Y; Deuel TF
Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
[TBL] [Abstract][Full Text] [Related]
11. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
Stoica GE; Kuo A; Aigner A; Sunitha I; Souttou B; Malerczyk C; Caughey DJ; Wen D; Karavanov A; Riegel AT; Wellstein A
J Biol Chem; 2001 May; 276(20):16772-9. PubMed ID: 11278720
[TBL] [Abstract][Full Text] [Related]
12. Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.
Czubayko F; Schulte AM; Missner SC; Hsieh SS; Colley KJ; Wellstein A
Breast Cancer Res Treat; 1995; 36(2):157-68. PubMed ID: 8534864
[TBL] [Abstract][Full Text] [Related]
13. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
Riegel AT; Wellstein A
Breast Cancer Res Treat; 1994; 31(2-3):309-14. PubMed ID: 7533562
[TBL] [Abstract][Full Text] [Related]
14. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant.
Zhang N; Zhong R; Wang ZY; Deuel TF
J Biol Chem; 1997 Jul; 272(27):16733-6. PubMed ID: 9201975
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferation.
Czubayko F; Downing SG; Hsieh SS; Goldstein DJ; Lu PY; Trapnell BC; Wellstein A
Gene Ther; 1997 Sep; 4(9):943-9. PubMed ID: 9349431
[TBL] [Abstract][Full Text] [Related]
16. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression.
Aigner A; Fischer D; Merdan T; Brus C; Kissel T; Czubayko F
Gene Ther; 2002 Dec; 9(24):1700-7. PubMed ID: 12457284
[TBL] [Abstract][Full Text] [Related]
17. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
18. Hammerhead ribozyme targeting connective tissue growth factor mRNA blocks transforming growth factor-beta mediated cell proliferation.
Blalock TD; Yuan R; Lewin AS; Schultz GS
Exp Eye Res; 2004 Jun; 78(6):1127-36. PubMed ID: 15109919
[TBL] [Abstract][Full Text] [Related]
19. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.
Yokoyama Y; Morishita S; Takahashi Y; Hashimoto M; Tamaya T
Br J Cancer; 1997; 76(8):977-82. PubMed ID: 9376277
[TBL] [Abstract][Full Text] [Related]
20. Pleiotrophin and midkine in normal development and tumor biology.
Kurtz A; Schulte AM; Wellstein A
Crit Rev Oncog; 1995; 6(2):151-77. PubMed ID: 8792088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
